Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1486-1496
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1486
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1486
Figure 2 Nomogram to predict the presence of hepatocellular carcinoma.
HBsAg: Hepatitis B surface antigen; TBA: Total bile acid; TBIL: Total bilirubin; GGT: Gamma-glutamyl transferase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AFP: Alpha-fetoprotein; PIVKA-II: Protein induced by vitamin K absence or antagonist-II; HCC: Hepatocellular carcinoma.
- Citation: Liu ZJ, Xu Y, Wang WX, Guo B, Zhang GY, Luo GC, Wang Q. Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes. World J Gastrointest Oncol 2023; 15(8): 1486-1496
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1486.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1486